Predicting drug penetration across the blood-brain barrier: comparison of micellar liquid chromatography and immobilized artificial membrane liquid chromatography by De Vrieze, Mike et al.
Predicting Drug Penetration Across the Blood-Brain Barrier: 
Comparison of  Micellar Liquid Chromatography and Immobilized 
Artificial Membrane Liquid Chromatography 
 
      M. De Vrieze1, F. Lynen1, P. Sandra1,2 
 
      1Laboratory for Separation Sciences, Department of Organic Chemistry, Ghent University,   
      Krijgslaan 281 S4-bis, B-9000 Ghent, Belgium 
      2 Pfizer Analytical Research Centre, Ghent University, Krijgslaan 281 S4-bis, B-9000 Ghent, Belgium 
INTRODUCTION 
    
  SDS provides a good log BB correlation on a C18-column 
  30% MeOH with a DPBS buffer gave a good log BB correlation 
  on an IAM column 
  The combination of  methods with different interaction mecha-
  nisms leads to a significant improvement in log BB prediction. 
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The Blood-Brain Barrier (BBB) permeability evaluation is an essential task for 
developing effective drugs for the treatment of the Central Nervous System 
(CNS). Both for drugs already on the market or under development, it is 
essential to know to what extent a drug enters the BBB. A common measure 
of the degree of BBB permeation is the ratio of the steady-state concentration 
of the drug molecule in the brain to the concentration in the blood, usually 
expressed as log (Cbrain/blood) or log BB [1]. 
 
In this study, 45 compounds with existing in vivo log BB values are analyzed 
with both Micellar Liquid Chromatography (MLC) and Immobilized Artificial 
Membrane (IAM) Liquid Chromatography. The capabilities towards log BB 
prediction are compared for both in vitro methods. 
 
MLC is a mode of Reversed Phase Liquid Chromatography (RPLC) which 
uses a surfactant solution above the Critical Micellar Concentration (CMC) as 
mobile phase. MLC is a fascinating example of the benefits of secondary 
equilibrium in RPLC. The primary equilibrium is solute partitioning between 
bulk solvent and the stationary phase. A secondary equilibrium is established 
with the micelles in the mobile phase (Figure 1A)[2]. 
 
IAMs mimic the lipid environment of a cell membrane. They are prepared by 
linking phospholipid analogues to silica particles. This can be used as an 
HPLC column packing material (Figure 1B)[3]. 
Figure 1: Schematic representation of  drug interactions (A) in Micellar Liquid Chromatography (MLC) and (B) in Immobilized 
Artificial Membrane (IAM) liquid chromatography. 
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In this study, MLC measurements were performed on a GraceSmart C18 
column (3 µm, 150 mm x 2.1 mm), the mobile phase flow rate was 0.2 ml/min. 
Three types of surfactants were used at a concentration of 0.05 M: Sodium 
Dodecyl Sulfate (SDS), polyoxy-ethylene (23) lauryl ether (Brij35) and Sodium 
DeoxyCholate (SDC). The surfactants were dissolved in a phosphate or 
borate buffer solution and the pH was set at 7.4. 
 
RESULTS & DISCUSSION 
CONCLUSION 
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IAM liquid chromatography measurements were performed on a Regis 
IAM.PC.DD2 column (10 µm, 150 mm x 4.6 mm), the mobile phase flow rate 
was 1 ml/min. The mobile phase was a mixture of methanol and Dulbecco’s 
Phosphate-Buffered Saline (DPBS). Measurements were performed with 
20%, 30% or 40% of methanol. 
 
 
 
MLC 
IAM 
The retention factors (k) of the compounds were obtained using various 
mobile phases. A Partial Least Squares (PLS) regression was performed in 
order to determine the correlation coefficient (R²) between the experimental 
(in vivo) log BB values and log BB values predicted using log k values and 
several other molecular descriptors.  
Log BB 
The results from the PLS regression are given in Table 1.  
The test set consisted of 45 compounds. Since the goal in this research is an 
accurate prediction of log BB values for any type of drug, only the conditions 
that allowed to measure all 45 compounds were considered interesting 
(indicated in gray). Measurements with SDS as surfactant gave the best 
correlation coefficient, but results from the IAM column were also quite good. 
 
The correlation between in vivo and predicted log BB values is shown in 
Figure 2 for the two conditions with the highest correlation coefficient. 
Although there are a few outsiders, the predicted log BB values for most 
compounds are very close to the experimentally (in vivo) determined values.  
 
SDS 
0.05 M 
IAM 
30% MeOH 
IAM 
20% MeOH 
IAM 
40% MeOH 
Brij35 
0.05 M 
SDC 
0.05 M 
# of compounds 43 36 39 45 45 45 
R² 0.8416 0.9213 0.8885 0.8659 0.8705 0.8689 
Table 1: Correlation coefficients between in vivo log BB values and predicted log BB values using log k values and several 
molecular descriptors. 
Combination of  MLC and IAM 
The selectivity for compounds is different when using a C18-column than when 
using an IAM-column (Figure 1). This has consequences towards the 
prediction of log BB values. An extra PLS 
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Figure 2: Visual representation of  the correlation between ‘In vivo’ and ‘Predicted’ log BB values (A) using SDS with MLC and 
(B) using 30% MeOH with IAM liquid chromatography. 
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regression was performed in order to 
determine the correlation coefficient 
between in vivo log BB values and 
predicted log BB values using log kSDS, 
log kIAM and several other molecular 
descriptors in the model. The obtained 
correlation coefficient was 0.8975 (Figure 
3), which is almost 1% better than the 
correlation coefficient using only log kSDS 
values (R² = 0.8885). The combination of 
these 2 types of log k values thus leads 
to a significant improvement in the 
prediction of brain-blood concentration 
values of drugs. 
Figure 3: Visual representation of  the correlation 
between ‘In vivo’ and ‘Predicted’ log BB values 
when combining MLC and IAM methods. 
